Vivek Mehta, M.D., is a radiation oncologist at Swedish Cancer Institute, Seattle, and a new member of the ITN Editorial Advisory Board.


Radiation oncology is an important area of concentration for Imaging Technology News (ITN), as we provide coverage of radiation therapy technology, treatment planning solutions and data management systems specifically for radiation oncology.

As we strive to further strengthen our expertise in this field, I am honored to welcome Vivek Mehta, M.D., a radiation oncologist at Swedish Cancer Institute, Seattle, to the ITN Editorial Advisory Board.
Dr. Mehta joined Swedish Cancer Institute in 2002, and is actively involved in designing and developing clinical research studies at Swedish Cancer Institute and through national research organizations, including the Southwestern Oncology Group.

His clinical interests include image-guided radiotherapy, balloon catheter-based breast brachytherapy, gamma knife radiosurgery, intensity modulated radiotherapy, stereotactic radiosurgery, and three-dimensional conformal radiotherapy.

Dr. Mehta has been involved in a number of clinical research studies and has been widely published in medical journals and publications. He has written several articles evaluating the use of concurrent chemotherapy and radiation in the management of malignancy, which he also presented at national and international meetings. His research has appeared in the peer-reviewed International Journal of Radiation Oncology, Biology and Physics, the American Journal of Clinical Oncology, Archives of Surgery, and the Journal of Gastrointestinal Surgery.

A graduate of Georgetown University, Dr. Mehta earned his medical degree from the University of Washington and completed his internship at both the Legacy Good Samaritan Medical Center and Legacy Emanuel Hospital in Portland, Ore. He completed his residency at Stanford University Medical, where he also served as chief resident in the radiation oncology department. He is board certified in therapeutic radiology.

In 2004 and 2006, Seattle magazine named Dr. Mehta one of the city’s top doctors in the area of radiation oncology. Other accolades include numerous resident/fellow research awards, such as the Malcolm A. Bagshaw Radiation Oncology Resident Award. He is the current scientific program chair for the Washington State Radiation Oncology Society and is also active in the American Society of Therapeutic Radiation Oncologists, the American College of Radiology and the American Association of Indian Physicians, and the American Society of Clinical Oncology.
In addition to his work at the Swedish Cancer Institute, Dr. Mehta is an assistant clinical professor at the University of Washington School of Medicine. To contact Dr. Mehta, e-mail him at: [email protected]


Related Content

News | Mammography

Nov. 26, 2025 — GE HealthCare has announced it received FDA Premarket Authorization for Pristina Recon DL, an advanced ...

Time November 29, 2025
arrow
News | Ultrasound Imaging

Nov. 12, 2025 — GE HealthCare and DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., have announced their ...

Time November 20, 2025
arrow
News | Breast Imaging

Nov. 17, 2025 — RadNet, Inc. and its wholly owned subsidiary, DeepHealth have announced results from the largest real ...

Time November 17, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
News | Lung Imaging

Nov. 3, 2025 — RevealDx, a leader in the characterization of lung nodules, has introduced MDR Certification of RevealAI ...

Time November 07, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
News | RSNA 2025

Nov. 3, 2025 — QT Imaging Holdings has announced that its chief medical officer, Elaine luanow, MD, will host a seminar ...

Time November 04, 2025
arrow
Subscribe Now